ACQUIREDT+2
Agomab Therapeutics NV · NASDAQ
+5,000 sh · $44.5K
Filed 9 Oct 2026SEC Form 4view source
- ACQUIREDT+7
Agomab Therapeutics NV · NASDAQ
+5,000 sh · $43.5K
Filed 7 Oct 2026SEC Form 4view source - ACQUIREDT+7
Agomab Therapeutics NV · NASDAQ
+5,000 sh · $42.9K
Filed 7 Oct 2026SEC Form 4view source - REDUCEDStale
Tempus AI Inc · NASDAQ
−250 sh · $16.4K
Filed 3 Sept 2026SEC Form 4view source